Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-13-024495
Filing Date
2013-08-05
Accepted
2013-08-05 17:58:40
Documents
1
Period of Report
2013-08-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 8194
  Complete submission text file 0001127602-13-024495.txt   9493
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JEFFS ROGER (Reporting) CIK: 0001231615 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 131011260